跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,548 条关于
“FOSUN INTERNATIONAL SECURITIES”
全部
8,548
临床试验
2,417
药物
158
机构
500
资讯
5,473
去年
AIM Vaccine's mRNA RSV Vaccine Advances to U.S. Clinical Trials with Superior Preclinical Results
2年前
Fosun Pharma and MingMed Achieve Key Regulatory Milestones for Novel Therapies
去年
Fosun Pharma's Innovative Drug Receives Registration Acceptance in China
4个月前
Arcera Life Sciences and Fosun Pharma Form Strategic Partnership to Bridge Chinese Innovation with Global Markets
去年
Vertex Pharmaceuticals Faces Securities Fraud Investigation After Disappointing Suzatrigine Trial Results
去年
Fosun Pharma Secures $645 Million Global Licensing Deal for Novel DPP-1 Inhibitor XH-S004
去年
Teva and Fosun Pharma Form Strategic Partnership for Novel Anti-PD1-IL2 Cancer Immunotherapy TEV-56278
5个月前
Fosun Pharma Receives NMPA Approval for Phase 1 Trial of HLX319 Biosimilar for Breast Cancer Treatment
去年
Fakeeh Care inks MoU with Fosun Pharma to develop cell, gene therapies
8个月前
Fosun Pharmaceutical Faces Market Skepticism Over $200 Million Green Valley Acquisition Amid Regulatory Concerns
第 1 页，共 548 页
上一页
下一页
